Search Results - Shammo, J.M

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del

    Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del by Skikne, B, Bennett, J.M, Sekeres, M.A, Giagounidis, A, Nimer, S.D, List, A.F, Knight, R.D, Fu, T, Shammo, J.M

    Published in Leukemia
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

    Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS by List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

    Published in Leukemia
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Blast Percentage Prior to Transplantation Is the Strongest Predictive Factor for Survival After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Patients with Myelodysplastic Syndrome (MDS)

    Blast Percentage Prior to Transplantation Is the Strongest Predictive Factor for Survival After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Patients with Myelodysplasti... by Jimenez, A.M, Rich, E.S, Nathan, S, Maciejewski, J, Shammo, J.M, Katz, D, Braun, E, Hashmi, S, Fung, H.C

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    S839 PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (MDS)

    S839 PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (MDS) by Navada, S.C., Garcia‐Manero, G., Atallah, E., Rajeh, M.N., Shammo, J.M., Griffiths, E.A., Khaled, S.K., Dakhil, S.R., Young, D.E., Odchimar‐Reissig, R., Demakos, E.P., Alvarado Valero, Y., Ohanian, M.N., Pemmaraju, N., John, R.B., Zbyszewski, P.S., Maniar, M., Petrone, M.E., Woodman, R.C., Fruchtman, S.M., Silverman, L.R.

    Published in HemaSphere
    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    First two cases of immune hemolytic anemia associated with ceftizoxime

    First two cases of immune hemolytic anemia associated with ceftizoxime by Shammo, J.M., Calhoun, B., Mauer, A.M., Hoffman, P.C., Baron, J.M., Baron, B.W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients

    Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients by Shammo, J.M., Smith, S.L., Bennett, M.V., Lee, H.W., Ostrander, A., Ross, A.A., Williams, S.F.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: